Red Cell Distribution Width (RDW) as a Prognostic Marker in Systemic Diseases: A Mini Review

Area of Science:

• Hematology
• Clinical Pathology
• Internal Medicine

Background:

• Red Cell Distribution Width (RDW) is a standard complete blood count parameter indicating red blood cell size variability.
• Initially used for anemia classification, RDW is now recognized as a prognostic indicator in diverse systemic conditions.
• Elevated RDW is linked to increased morbidity and mortality in cardiovascular, renal, metabolic, infectious, inflammatory, and malignant diseases.

Purpose of the Study:

• To review the prognostic significance of RDW in systemic diseases.
• To explore potential pathophysiological mechanisms linking RDW to disease progression.
• To highlight RDW's utility in clinical decision-making and risk stratification.

Main Methods:

• Systematic review of current evidence on RDW's prognostic value.
• Analysis of studies correlating RDW levels with disease severity and patient outcomes.
• Exploration of underlying biological mechanisms, including inflammation, oxidative stress, and erythropoiesis.

Main Results:

• Elevated RDW is associated with adverse outcomes in conditions like heart failure, sepsis, COPD, and cancer.
• RDW changes may reflect underlying systemic inflammation, oxidative stress, nutritional status, or bone marrow dysfunction.
• RDW serves as a cost-effective, non-invasive biomarker for risk stratification and monitoring.

Conclusions:

• RDW demonstrates significant prognostic value across a spectrum of systemic diseases.
• Further research is needed to fully elucidate the pathophysiological links between RDW and disease progression.
• Standardization and validation are crucial for integrating RDW into routine clinical practice for enhanced patient management.